Adaptimmune Therapeutics plc (ADAP) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Adaptimmune Therapeutics plc's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
48/100
Fair
Valuation Metrics
P/E Ratio
-1.92
Weak
WeakModerateStrong
P/B Ratio
11.47
Strong
WeakModerateStrong
Earnings Yield
-52.10%
Weak
WeakModerateStrong
Profitability Health
Return on Equity
-597.64%
Weak
WeakModerateStrong
Operating Margin
-38.62%
Weak
WeakModerateStrong
Net Profit Margin
-39.78%
Weak
WeakModerateStrong
Growth Indicators
Revenue Growth
195.34%
Strong
WeakModerateStrong
Net Income Growth
37.81%
Strong
WeakModerateStrong
EPS Growth
50.42%
Strong
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
2.92
Strong
WeakModerateStrong
Quick Ratio
2.80
Strong
WeakModerateStrong
Asset Turnover
0.72x
Moderate
WeakModerateStrong
Inventory Turnover
0.01x
Weak
WeakModerateStrong